Evaluation of CD160 and CD200 Expression as Differentiating Markers between Chronic Lymphocytic Leukemia and Other Mature B-Cell Neoplasms.

Wafaa Ahmed El-Neanaey, Rania Shafik Swelem, Omar Mohamed Ghallab, Sara Mohamed Abu-Shelou

Open access · diamondAbstract read

In one paragraph

Article in International journal of hematology-oncology and stem cell research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it

0cells of the map it votes in

4citing papers in PubMed

0.3field-weighted citation impact, top 45% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

Bruton's Tyrosine Kinase Inhibitors: Mechanisms, Efficacy, Toxicities and Applications for the Treatment of Human Diseases.MedComm · 2026
Review
Aberrant Expression ofCancers · 2025
Article
The Use of CD200 in the Differential Diagnosis of B-Cell Lymphoproliferative Disorders.British journal of biomedical science · 2023
Article
CD200 and Chronic Lymphocytic Leukemia: Biological and Clinical Relevance.Frontiers in oncology · 2020
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wafaa Ahmed El-NeanaeyDepartment of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

Rania Shafik SwelemDepartment of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

Omar Mohamed GhallabDepartment of Internal Medicine (Hematology), Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

Sara Mohamed Abu-ShelouDepartment of Clinical and Chemical Pathology, Faculty of Medicine, University of Alexandria, Alexandria, Egypt.

Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CD160CD200CLLFlow cytometryMature B-cell neoplasms

Identifiers

PMID32337012

PMCPMC7167601

OpenAlexW3002218068

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.